Atrial fibrillation (AF) has strong associations with other cardiovascular diseases, such as heart failure, coronary artery disease (CAD), valvular heart disease, diabetes mellitus, and hypertension.Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.Whether AF is a complication of myocardial infarction or a marker for myocardial infarction severity is unclear.CHADS2 Score for Stroke Risk Assessment in Atrial Fibrillation.
Information on atrial fibrillation | Patients on apixaban
Hospital-Based Quality Improvement in Stroke PreventionColchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study.Isolation or elimination of these foci can lead to elimination of the trigger for paroxysms of AF.Thank you for your interest in spreading the word about The BMJ.
New Study Compares Stroke Prevention Treatments for Non-valvular Atrial Fibrillation Patients.Anticoagulation in Atrial Fibrillation: To Bridge or Not to Bridge.Thus, long-term AF screening strategies can be considered in these patients similar to the current standard of practice for patients with cryptogenic stroke.Patients with persistent AF also include those with longstanding AF in whom cardioversion has not been indicated or attempted, often leading to permanent AF.Atrial fibrillation increases the risk of stroke, which is a leading cause of death and disability worldwide.Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
No antithrombotic therapy, anticoagulant therapy, or aspirin therapy may be considered.Findings from 12-lead electrocardiography (ECG) usually confirm the diagnosis of AF and include the following.Treatment Options for Patients with Nonvalvular Atrial Fibrillation.Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service.Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy.
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.This model is supported by data from patients with paroxysmal AF demonstrating that widespread distribution of abnormal atrial electrograms predicts progression to persistent AF.Insulin resistance and atrial fibrillation (from the Framingham Heart Study).Histopathological substrate for chronic atrial fibrillation in humans.Vernakalant hydrochloride: a novel atrial-selective agent for the cardioversion of recent-onset atrial fibrillation in the emergency department.
Overview of atrial fibrillation - UpToDateSimple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.The risk of stroke from AF that lasts longer than 24 hours is a major concern and is usually addressed by prescribing a blood thinner (warfarin, dabigatran, rivaroxaban, apixaban, or edoxaban).
Newer oral anticoagulants that have been approved by the US Food and Drug Administration (FDA) include the following.Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the Embolism in Left Atrial Thrombi (ELAT) Study.Initial history and physical examination include the following.Kuck KH, Brugada J, Furnkranz A, et al, for the FIRE AND ICE Investigators.Connolly SJ, Pogue J, Hart RG, et al, for the ACTIVE Investigators.The mainstay of treatment in both guidelines remains. to-head trials against warfarin for non-valvular atrial fibrillation. 27.